🔎 Trials Near Me

Home › Non-Small Cell Lung Cancer › Ohio › Toledo

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Toledo, OH

Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Toledo. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 2
  • Mercy Health - Perrysburg Cancer Center /ID# 270536, Perrysburg · 8 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06568939

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Nagre-recruitPhase 3
  • ProMedica Flower Hospital, Sylvania · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07388524

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nagre-recruitPhase 3
  • Mercy Health - Saint Anne Hospital, Toledo
  • Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi ang layo
  • ProMedica Flower Hospital, Sylvania · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04267848

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Nagre-recruitPhase 3
  • Taylor Cancer Research Center, Maumee · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06881784

Pan-tumor MRD Study

Nagre-recruitObservasyonal na pag-aaral
  • Taylor Cancer Research Center, Maumee · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06605404

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Nagre-recruitPhase 3
  • Research Site, Toledo
  • Research Site, Maumee · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06357533

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Nagre-recruitObservasyonal na pag-aaral
  • Toledo Clinic Cancer Center, Toledo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Nagre-recruitPhase 2
  • Mercy Health - Saint Anne Hospital, Toledo
  • Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi ang layo
  • ProMedica Flower Hospital, Sylvania · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05642572

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Nagre-recruitPhase 1/2
  • Taylor Cancer Research Center, Maumee · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT05379985

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2
  • ProMedica Flower Hospital, Sylvania · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2/3
  • ProMedica Flower Hospital, Sylvania · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2
  • ProMedica Flower Hospital, Sylvania · 9 mi ang layo
18 Minutes · Lahat ng kasarian · Na-update May 5, 2026 · NCT06031688

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2
  • Taylor Cancer Research Center, Maumee · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 18, 2026 · NCT07030257

GEMINI-NSCLC: NSCLC Biomarker Study

Nagre-recruitObservasyonal na pag-aaral
  • Taylor Cancer Research Center, Maumee · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 5, 2026 · NCT05236114

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Nagre-recruitPhase 1/2
  • Taylor Cancer Research Center (site 204), Maumee · 9 mi ang layo
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT03556228

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Toledo

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.